Med-IQ Logo
Get CME/CE
Med-IQ Express

Med-IQ Express is an innovative, CME platform that fits into your busy schedule. Featuring 15-minute, CME-certified activities, it provides the quality you’ve come to expect from Med-IQ with the convenience you need. Med-IQ Express delivers focused clinical content at your fingertips in a format that includes a video vignette followed by an interactive digital publication, all built for compatibility with your smartphone and other mobile devices.

The Evolving Therapeutic Landscape for Moderate-to-Severe Atopic Dermatitis

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This CME-certified activity focuses on breakthrough therapy in clinical development for the treatment of patients with moderate-to-severe atopic dermatitis. It begins with a brief video in which an expert dermatologist offers clinical commentary; the clinical science regarding the use of targeted agents that inhibit cytokines involved in T helper 2 polarization…More

The Evolving Therapeutic Landscape for Moderate-to-Severe Atopic Dermatitis

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This CME-certified activity focuses on breakthrough therapy in clinical development for the treatment of patients with moderate-to-severe atopic dermatitis. It begins with a brief video in which an expert dermatologist offers clinical commentary; the clinical science regarding the use of targeted agents that inhibit cytokines involved in T helper 2 polarization…More

Evolutions in Short Bowel Syndrome Management: Critical Updates

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute publication begins with a brief video in which a clinical expert provides an overview of short bowel syndrome, including the consequences of long-term parenteral nutrition and its effects on a patient’s quality of life. Treatment strategies to reduce patient dependence on parenteral nutrition are then discussed in the online publication.

Prolonging Survival in Patients With Metastatic Colorectal Cancer Using Novel VEGF-Directed, Antiangiogenic Agents

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute publication begins with a brief video in which a clinical expert reviews the use of antiangiogenic agents in patients with progressive metastatic colorectal cancer (mCRC). The publication then presents key guideline recommendations and a focused discussion on pivotal trials of the 4 main agents used to prolong survival in patients with mCRC.

Prolonging Survival in Patients With Metastatic Colorectal Cancer Using Novel VEGF-Directed, Antiangiogenic Agents

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute publication begins with a brief video in which a clinical expert reviews the use of antiangiogenic agents in patients with progressive metastatic colorectal cancer (mCRC). The publication then presents key guideline recommendations and a focused discussion on pivotal trials of the 4 main agents used to prolong survival in patients with mCRC.


Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer: A Focus on Colony-Stimulating Factors

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This activity presents the latest guideline recommendations for identifying patients with breast cancer who have a risk of developing chemotherapy-induced neutropenia. It also provides guideline-based strategies for initiating preventive treatment, with a special focus on evidence associated with available and emerging granulocyte colony-stimulating factors.